首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats.
【24h】

Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats.

机译:单胺类药物调节由二苯二硒化物引起的抗抑郁样作用。

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, the antidepressant-like effect caused by diphenyl diselenide on rat forced swimming test (FST) was investigated. The involvement of the monoaminergic system in the antidepressant-like effect was also evaluated. Diphenyl diselenide (0.1-30 mg/kg), given by oral route (p.o.), 30 min earlier, reduced the immobility time in the FST, without accompanying changes in ambulation when assessed in an open field. The anti-immobility effect of diphenyl diselenide (1 mg/kg, p.o.) on the FST was prevented by pretreatment of rats with p-chlorophenylalanine methyl ester (PCPA; 100 mg/kg, i.p., an inhibitor of serotonin synthesis, given once a day, for 3 consecutive days), WAY100635 (0.1 mg/kg, s.c., a selective 5-HT(1A) receptor antagonist), ketanserin (1 mg/kg, i.p., a 5-HT(2A)/(2C) receptor antagonist), ondasentron (1 mg/kg, i.p., a 5-HT(3) receptor antagonist), haloperidol (1 mg/kg, i.p., a D(1), D(2) and D(3) receptor antagonist), SCH233390 (0.05 mg/kg, s.c., a D(1) receptor antagonist), sulpiride (50 mg/kg, i.p., a D(2) receptor antagonist), prazosin (1 mg/kg, i.p., an alpha(1)-adrenoceptor antagonist), yohimbine (1 mg/kg, i.p., an alpha(2)-adrenoceptor antagonist). However, the anti-immobility effect caused by diphenyl diselenide (1 mg/kg, p.o.) on the FST was not affected by pretreatment with propanolol (2 mg/kg, i.p., a beta-adrenoceptor antagonist). Furthermore, monoamine oxidase (MAO) activity was inhibited (39%) in the animals treated with diphenyl diselenide (30 mg/kg, p.o.) when compared to the control group. Taken together these data demonstrated that the antidepressant-like effect caused by diphenyl diselenide seems to be mediated by involvement of the central monoaminergic system.
机译:在这项研究中,研究了二苯二硒化物对大鼠强迫游泳试验(FST)的抗抑郁样作用。还评估了单胺能系统在类抗抑郁药中的作用。口服(p.o.)提前30分钟给予二苯二硒化物(0.1-30 mg / kg),可以减少FST的固定时间,而在空旷地区进行评估时,行走情况不会发生变化。用对氯苯丙氨酸甲酯(PCPA; 100 mg / kg,ip,5-羟色胺合成抑制剂)对大鼠进行预处理,预防二苯二硒(1 mg / kg,口服)对FST的抗固定作用。连续3天),WAY100635(0.1 mg / kg,sc,选择性5-HT(1A)受体拮抗剂),酮色林(1 mg / kg,ip,5-HT(2A)/(2C)受体拮抗剂),ondasentron(1 mg / kg,ip,5-HT(3)受体拮抗剂),氟哌啶醇(1 mg / kg,ip,D(1),D(2)和D(3)受体拮抗剂) ,SCH233390(0.05 mg / kg,sc,D(1)受体拮抗剂),舒必利(50 mg / kg,ip,D(2)受体拮抗剂),哌唑嗪(1 mg / kg,ip,alpha(1) )-肾上腺素受体拮抗剂),育亨宾(1 mg / kg,腹膜内注射,α(2)-肾上腺素受体拮抗剂)。但是,二苯二硒化物(1 mg / kg,p.o。)对FST的抗固定作用不受丙醇(2 mg / kg,即β-肾上腺素受体拮抗剂)预处理的影响。此外,与对照组相比,用二苯基二硒化物(30 mg / kg,p.o。)治疗的动物单胺氧化酶(MAO)活性受到抑制(39%)。这些数据加在一起表明,由二苯二硒化物引起的抗抑郁样作用似乎是由中央单胺能系统的参与介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号